 TEL AVIV, Israel , Oct. 28, 2022 PRNewswire -- Chemomab Therapeutics Ltd. Nasdaq: CMMB, Chemomab, a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that the company will participate in several scientific conferences in November. 